A Novel, Highly Sensitive Antibody Allows for the Routine Detection of <i>ALK</i> -Rearranged Lung Adenocarcinomas by Standard Immunohistochemistry

Abstract

Low levels of ALK protein expression is a characteristic feature of ALK-rearranged lung adenocarcinomas. However, a novel, highly sensitive IHC assay reliably detects lung adenocarcinomas with ALK rearrangements and obviates the need for fluorescence in situ hybridization analysis for the majority of cases, and therefore could be routinely applicable in clinical practice to detect lung cancers that may be responsive to ALK inhibitors.